Biostage (BSTG) Environmental, Social & Governance (ESG) Data

Company Profile

Search within these filings

View filings

Exhibits within filings

Filing insights

Export filings list

Export a CSV file of filings or unique filing companies (up to first 5,000 results).

Download list of filings Download list of companies

Employees

Data from SEC filings

Employee count

ESG framework mentions

In last year of SEC filings

Sustainability Accounting Standards Board (SASB)

No mentions

Global Reporting Initiative (GRI)

No mentions

Task Force on Climate-related Financial Disclosures (TCFD)

No mentions

UN Sustainable Development Goals (SDGs)

No mentions

ESG term mentions

In last year of SEC filings

Carbon Clean Conservation Environment Environmental Environmental Protection Green Lifecycle Materials Nature Offset Package Packaging Pandemic Plastic Raw Materials Regeneration Regenerative Toxic Waste Water Access Asian Benefits Black Community Culture Customer Cyber Death Disability Diversity Drug Pricing Employee Employee Retention Engagement General Data Protection Regulation Health and Safety Health Care Healthcare Hire Hiring Human Capital Human Resources Injuries Injury Minority Privacy Product Safety Recall Recruit Recruitment Reimbursement Retention Retirement Safety Satisfaction Skill Skilled Skills Social Society Stakeholder Supplier Supply Chain Training Union Unionized Volunteer Assessment Assurance Audit Bonus Bribery Classified Commitment Corporate Governance Corporate Purpose Department of Ethics Executive Compensation Expert Fraud Goals Governance Incentive Incentivize Independence Independent Innovate Innovation Innovative Investigation Lawsuit Leadership Litigation Long-term Majority Mission Oversee Oversight Plaintiff Purpose R&D Reputation Research and Development Responsibility Responsible Special Meeting Strategy Targets Tax Tenure Transparency Voting Rights

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

On July 28, 2022, Biostage, Inc., or the Company, held a Special Meeting of Stockholders, or the Special Meeting. At the Special Meeting, the Company’s stockholders voted on the approval of a proposed amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended, to effect a reverse split of the Company’s issued and outstanding common stock at a ratio of not less than 1-for-1.25 and not greater than 1-for-5, with the final decision of whether to proceed with the reverse stock split and the exact ratio and timing of the reverse split to be determined by the Company’s Board of Directors, in its discretion, following stockholder approval but no later than July 28, 2023. Such proposal was approved the Company’s stockholders as follows:

Votes For				Votes Against				Votes Abstained				Broker Non-Votes

	7,072,052				196,116				742				0